Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: 1201643-08-4 | Product Number: D4898
BD140 [for Albumin binding assay]
Purity: >98.0%(GC)
- 4,4-Difluoro-1-methyl-3-(4-propoxystyryl)-4-bora-3a,4a-diaza-s-indacene
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
25MG |
$301.00
|
1 | 2 | 7 |
|
100MG |
$867.00
|
2 | 2 | ≥40 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | D4898 |
Purity / Analysis Method | >98.0%(GC) |
Molecular Formula / Molecular Weight | C__2__1H__2__1BF__2N__2O = 366.22 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Condition to Avoid | Light Sensitive |
CAS RN | 1201643-08-4 |
Reaxys Registry Number | 19925561 |
PubChem Substance ID | 354333597 |
Purity(GC) | min. 98.0 % |
Melting point | 153.0 to 157.0 °C |
Lambda max. | 563.0 to 567.0 nm(CH2Cl2) |
Molar extinction coefficient | min. 10000(CH2Cl2, 563.0 to 567.0nm) |
Human serum albmin (HSA) binding activity | S/N ratio min. 10 |
Competitive avtivity in competitive drug | Remaining fluorescein inensity max. 20 % |
Non-competitive avtivity in non-competitive drug | Remaining fluoresein intensity min. 80 % |
Melting Point | 155 °C |
Maximum Absorption Wavelength | 565(CH2Cl2) nm |
Pictogram | |
Signal Word | Warning |
Hazard Statements | H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
Precautionary Statements | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P302 + P352 : IF ON SKIN: Wash with plenty of soap and water. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P362 : Take off contaminated clothing and wash before reuse. |
HS Number | 2934.99.4400 |
References
- 1)The Characterization of Two Specific Drug Binding Sites on Human Serum Albumin
- 2)Further Characterization of Specific Drug Binding Sites on Human Serum Albumin
- 3)Fluorescent Dye Cocktail for Multiplex Drug-Site Mapping on Human Serum Albumin
Buffer: 1% DMSO in phosphate buffer (pH7.2 - 7.5), HSA: 20 µM (50 µL/well), Drugs: each concentration (50 µL/well), BD140: 20 µM(50 µL/well), Incubation: 20-25°C for 30 min, Measurement: plate-reader; excitation=365 nm, emission=585 nm.
References
- Fluorescent Dye Cocktail for Multiplex DrugSite Mapping on Human Serum Albumin
- Structural and functional insights into S-thiolation of human serum albumins
- 8‐Prenylnaringenin tissue distribution and pharmacokinetics in mice and its binding to human serum albumin and cellular uptake in human embryonic kidney cells
Articles/Brochures
[Product Highlights] Fluorescent Probes for the Characterization of Two Specific Drug Binding Sites on HSA
[Product Highlights] Fluorescent Probe for Human Serum Albumin (HSA)-Drug Binding Assay
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.